Unique ID issued by UMIN | UMIN000054051 |
---|---|
Receipt number | R000061712 |
Scientific Title | Research quality of clinical trials reported for Foods with Functional Claims in Japan: evaluation based on a revised tool to assess risk of bias in randomized trials (RoB 2) |
Date of disclosure of the study information | 2024/04/04 |
Last modified on | 2024/04/03 15:52:51 |
Research quality of clinical trials reported for Foods with Functional Claims in Japan: evaluation based on a revised tool to assess risk of bias in randomized trials
Research quality of clinical trials reported for Foods with Functional Claims in Japan
Research quality of clinical trials reported for Foods with Functional Claims in Japan: evaluation based on a revised tool to assess risk of bias in randomized trials (RoB 2)
Research quality of clinical trials reported for Foods with Functional Claims in Japan
Japan |
Nothing
Adult |
Others
NO
This study aims to evaluate the risk of bias using "A revised tool to assess risk of bias in randomized trials (RoB 2)"for notifications based on recent clinical trials (CTs) published on the Japanese Consumer Affairs Agency (CAA) website, and to clarify the characteristics associated with them.
Others
What is the relationship between the following four items: the quality of research methodology and the affiliations of the author (for-profit researcher, academia researcher), the year in which the paper was published, English versus Japanese language, and the journal impact factor. We will also look at issues that could be improved for these items.
Overall RoB 2 score
Each domain score
Others,meta-analysis etc
18 | years-old | <= |
84 | years-old | >= |
Male and Female
All submitted papers based on CTs published on the CAA website during the period from January 1, 2024 to June 30, 2024* are eligible. Papers based on systematic reviews and observational studies will be excluded. If there is overlap, such as multiple notifications using the same paper as proof of functionality, only the first paper will be accepted.
*The health hazards detected in March 2024 that were caused by supplements manufactured and sold by KOBAYASHI Pharmaceutical Co., Ltd. have become a major social issue. As a result, the study period may be extended if the number of samples is small due to delays in notifications to the CAA.
In this study, intervention studies (single-arm) without a comparison group will be excluded as a research design.
1st name | Hiroharu |
Middle name | |
Last name | Kamioka |
Tokyo University of Agriculture
Department of Regional Environment Science
156-8502
Sakuragaoka 1-1-1, Setagaya-ku, Tokyo
0354772587
h1kamiok@nodai.ac.jp
1st name | Hiroharu |
Middle name | |
Last name | Kamioka |
Tokyo University of Agriculture
Department of Regional Environment Science
156-8502
Sakuragaoka 1-1-1, Setagaya-ku, Tokyo
0354772587
h1kamiok@nodai.ac.jp
Tokyo University of Agriculture
Grant-in-Aid for Scientific Research (C) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT)
Japanese Governmental office
IRB, Tokyo University of Agriculture
Sakuragaoka 1-1-1, Setagaya-ku, Tokyo
0354772532
h1kamiok@nodai.ac.jp
NO
2024 | Year | 04 | Month | 04 | Day |
https://1drv.ms/b/s!AoQmpnIHE3YUhMo58Yre7E_YSnXQzw?e=VdKCMF
Unpublished
Preinitiation
2024 | Year | 04 | Month | 03 | Day |
2024 | Year | 04 | Month | 15 | Day |
2024 | Year | 06 | Month | 30 | Day |
Organization (Researchers)
Hiroharu Kamioka 1,*
Kiichiro Tsutani 2
Hideki Origasa 3
Jun Kitayuguchi 4
1 Faculty of Regional Environment Science, Tokyo University of Agriculture, 1-1-1 Sakuragaoka,
Setagaya-ku, Tokyo 156-8502, Japan
2 Physical Education and Medicine Research Center Unnan, 328 Uji, Unnan City, Shimane 699-1105, Japan
3 Institute of Statistical Mathematic, 10-3 Midori-cho, Tachikawa City, Tokyo 190-8562, Japan
4 The Institute of Seizon and Life Sciences, 4-5-1 Ginza, Chuo-ku, Tokyo 104-0061, Japan
* Correspondence: h1kamiok@nodai.ac.jp
Research collaborators
We will mainly utilize Ms. Michiko Ishida for paper work and Ms. Mari Makishi and Ms. Satoko Sayama for collecting related papers.
Author Contributions
HK conceived and designed the study and will make a brief summary list of included studies and data extraction, and evaluating the quality of articles. JK will carry out statistical analysis. HO will confirm the appropriateness of the analysis method. HK will describe the draft article. KT and HO will be the guarantors.
Conflicts of Interest
HK supervised systematic reviews for five corporations (FANCL CORPORATION, Morishita Jintan Co., Ltd., KAGOME Co., Ltd., MARUZEN PHARMACEUTICAL CO., LTD., SUNTORY WELLNESS LIMITED, Suntory Beverage & Food Limited, and FUJIFILM Corporation) and was compensated for that work. The other authors have no conflicts to declare.
2024 | Year | 04 | Month | 03 | Day |
2024 | Year | 04 | Month | 03 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000061712
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |